Neuralink · 2 months ago
Biocompatibility Scientist
Austin, Texas, United States
Full-time
Onsite
Entry, Mid Level
$71K/yr - $119K/yr
1+ years expNeuralink is creating devices that enable a bi-directional interface with the brain, aiming to restore movement and sight. The Biocompatibility Scientist will develop in-vitro biocompatibility methods to ensure the safety and regulatory compliance of these innovative medical devices.
BiotechnologyMedicalNeuroscienceRobotics
Responsibilities
Assist with the setup of necessary laboratory equipment, including calibration and qualification, if needed
Lead the development, validation, and ongoing sustainment of in-vitro biocompatibility assays, ensuring reproducibility, appropriate endpoints, and compliance with international guidance
Support general laboratory operations, including equipment management, calibration, and routine maintenance tasks to maintain a safe and efficient workspace
Collaborate with engineering teams to provide expert consultation on the selection of materials and chemical agents used in manufacturing processes
Prepare toxicological risk assessment reports, biological safety evaluations, and contribute to FDA and international regulatory submissions
Own toxicological risk assessment (TRA), including developing and documenting standard operating procedures (SOPs) that outline the TRA process and utilizing risk assessment tools such as the QSAR toolbox, read-across methodologies, and other risk assessment resources
Conduct hazard identification, literature reviews, and dose-response assessments to support TRA
Interpret chemical characterization data in accordance with ISO 10993 standards and integrate findings into comprehensive biocompatibility assessments for medical devices
Qualification
Required
B.S. in molecular biology, toxicology, pharmacology, biochemistry, or a related field
Strong background in cell biology, molecular biology, and/or toxicology
>1 year of experience with in-vitro method development (including academic or research experience)
Proficiency with confocal microscopy
Excellent analytical, problem-solving, and communication skills, with the ability to collaborate across interdisciplinary teams
Ability to conduct thorough literature searches
Preferred
M.S. or PhD in toxicology, pharmacology, biochemistry, or a related field
Strong knowledge of ISO 10993 standards and experience with chemical characterization and biocompatibility evaluations
Familiarity with in-vivo models
>3 years of experience in toxicological risk assessment, preferably in the medical device industry or pharmaceutical industry
Certification as a Diplomate of the American Board of Toxicology (DABT) or similar professional credential
Familiarity with FDA and international regulatory submissions
Benefits
An opportunity to change the world and work with some of the smartest and most talented experts from different fields
Growth potential; we rapidly advance team members who have an outsized impact
Excellent medical, dental, and vision insurance through a PPO plan
Paid holidays
Commuter benefits
Meals provided
Equity (RSUs) *Temporary Employees & Interns excluded
401(k) plan *Interns initially excluded until they work 1,000 hours
Parental leave *Temporary Employees & Interns excluded
Flexible time off *Temporary Employees & Interns excluded
Company
Neuralink
Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.
201-500 employees
H1B Sponsorship
Neuralink has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (14)
2023 (7)
2022 (5)
2021 (7)
2020 (6)
Funding
Current Stage
Late StageTotal Funding
$1.34BKey Investors
CoreNest CapitalFounders FundVy Capital
2025-07-07Series Unknown
2025-06-17Secondary Market
2025-05-27Series E· $649M
Leadership Team
Dongjin Seo
Co-Founder, President & COO
Shivon Zilis
Director of Operations and Special Projects
Recent News
2026-01-09
Company data provided by crunchbase